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University of Brest, Laboratory of Skin Neurobiology, Brest, France
Merkel cells (MCs) are neuroendocrine cells which are located in the basal layer 
of the epidermis. Their origin is still discussed but new arguments are in favour of 
an epidermal origin rather than a neural-crest origin. MCs are in close contact with 
nerve endings and their role was limited to an involvement in mechanosensory 
function until recently. New data indicate that they can be considered as 
mechanoreceptors by themselves. Because they are dendritic cells and produce 
neurotransmitters, a very important role as a mediator between epidermal cells 
and the nervous system has been suggested. Nowadays, it is confi rmed that MCs 
are regulatory cells in the neuro-endocrino-immuno-cutaneous system (NEICS). 
Due to new possibilities to isolate and culture them, knowledges about MCs 
are more numerous. The interest about these cells is renewed since the role 
of a new polyomavirus in the genesis of Merkel cell carcinoma (MCC) has been 
discovered. Indeed, Merkel cell polyomavirus (MCV) is present in most MCC and 
is very important in this cancer. This is a new very stimulating fi eld of research.
The Effect of Neuropeptides on CLA+ T Cells in Atopic Dermatitis
Luis F Santamaria-Babi
Institute for Research in Biomedicine, Barcelona, Spain 
Pruritus in atopic dermatitis (AD) can be treated with immunosuppressants or 
corticosteroids indicating the involvement of T-cell dependent mechanisms in this 
relevant symptom of AD. Memory effector CLA+ T cells constitute a very relevant 
T cell subset involved in AD. This skin-homing subset of memory T cells are found 
in AD lesions, preferentially responds to cutaneous allergens, bear Staphylococcus 
aureus responsive TCRVβ segments, and produce Th2 or Th1 cytokines depending on 
AD stage. In addition, these lymphocytes express an array of adhesion molecules and 
chemokines receptors (CCR10 and CCR4) that direct them from blood to infl amed 
skin lesion, source of their specifi c ligands. Mental stress increases the frequency of 
circulating CLA+ T cells in comparison to healthy individuals. CLA+ T cells are also 
producers of IL-31 whose receptor is present in dorsal root ganglia and that when 
overexpressed in the mouse induces pruritus. During AD CLA+ T cells recirculate 
between skin lesion and blood, since during anti-LFA-1 treatment increases in 
peripheral blood CLA+ T cells are observed. Unfortunately, there are few studies 
exploring the direct effect of neuropeptides in CLA+ T cells from AD patients. The 
neuropeptides somatostatin, calcitonin gene-related peptide (CGRP), and substance 
P were studied for their stimulatory activity on peripheral CLA+/CLA- T cells of AD 
patients and controls. CGRP preferentially induced increased production of IL-13 
in CLA+ T cells from AD patients. This effect was limited to CD45R0+ (memory) 
T cells and not to CD45RA+ (naïve) T cells. CGRP lead to CLA+ T cell activation 
since increased the expression of the T-cell activation marker HLA-DR. The CGRP 
effect could be inhibited by a CGRP antagonist indicating the selective of the 
effect. The fact that CGRP preferentially activates CLA+ T cell without the need 
of TCR engagement could help to study neurogenic infl ammation in AD with a 
subpopulation of memory T cells which are clearly involved in AD pathogenesis.
Neurotrophin Receptors in Healthy and Psoriatic Epidermis
Carlo Pincelli
Laboratory of Cutaneous Biology, University of Modena and Reggio Emilia, Italy
p75 neurotrophin receptor (p75NTR) belongs to the TNF-receptor superfamily and 
signals apoptosis in many cell settings. We evaluated the expression and function 
of p75NTR in human keratinocytes. p75NTR was only expressed in the basal 
keratinocyte layer and confi ned to transit amplifying cells (TA). Moreover, calcium 
treatment of subconfl uent keratinocytes induced the up-regulation of p75NTR 
concurrently with the expression of the differentiation marker. p75NTR retroviral 
infection of stem cells induced a more differentiated phenotype with the same 
features of like TA cells. On the other hand, when p75NTR was silenced, calcium 
treatment failed to induce differentiation in subconfl uent keratinocytes. Moreover, 
β-amyloid, a ligand for p75NTR, induced apoptosis in human keratinocytes only in 
p75NTR expressing keratinocytes, as shown by caspase-3 activation. Brain-derived 
neurotrophic factor (BDNF) or neurotrophin-4 (NT-4), which signal through p75NTR, 
determined a higher rate of apoptosis in HaCaT cells overexpressing p75NTR. 
On the other hand, NT-4 failed to induce cell death in p75NTRsiRNA transfected 
HaCaT cells. Because psoriasis is characterized by a dysregulation of epidermal 
homeostasis, namely alteration of differentiation and resistance to apoptosis, 
we evaluated the expression and function of p75NTR in this disease.  p75NTR 
was absent in lesional psoriatic skin and p75NTR levels were signifi cantly lower 
in psoriatic than in normal TA keratinocytes. The rate of apoptosis in psoriatic TA 
cells was signifi cantly lower, as compared to normal TA cells. p75NTR retroviral 
infection restored apoptosis in psoriatic keratinocytes. These results suggest that 
p75NTR has a dual role: it acts as a “switch on-off” in differentiation and/or as a pro-
apoptotic receptor. Thus, p75NTR is essential for maintaining epidermal homeostasis. 
Sebaceous Gland – the Brain of the Skin
Christos C. Zouboulis
Departments of Dermatology, Venereology, Allergology and Immunology, Dessau 
Medical Center, Dessau, Germany
Current evidence suggests that, in addition to the central nervous system, at least 
some neuropeptides and their receptors are released/expressed in peripheral 
tissues. In the skin, this important endocrine function has been designated to the 
sebaceous glands, which also produce androgens, estrogens, all-trans retinoic acid, 
cortisol, vitamin D3 and eicosanoids. Synthesis of corticotropin-releasing hormone 
(CRH) in sebocytes indicates that endocrine stress responses can also occur outside 
of the classical hypothalamus-pituitary-adrenal axis. CRH-binding protein and 
CRH receptors (CRHR-1 and -2) have also been shown to be expressed in human 
sebaceous glands. CRH directly upregulates 3β-Δ5-4-hydroxysteroid dehydrogenase, 
the enzyme that converts dehydroepiandroestrone to testosterone. Moreover, CRH 
stimulates the synthesis of neutral (sebaceous) lipids and of IL6 and IL8 in human 
sebocytes. Intracellular CRH expression is increased in acne-involved sebaceous 
glands, it activates and degranulates mast cells and releases histamine and several 
infl ammatory cytokines and also induces skin vasodilatation via mast cell-dependent 
pathways. In addition, sebocytes express melanocortin 1 and 5 receptors, which 
bind α-MSH, µ-opiate receptors, which bind β-endorphin. VPAC receptors, which 
bind vasoactive intestinal popypeptide, receptors for neuropeptide Y and calcitonin 
gene-related peptide, cannabinoid receptors 1 and 2, and histamine 1 receptor. 
Interestingly, genes expressed in signalling pathways operative in age-associated 
neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, 
Huntington’s disease, dentatorubral-pallidoluysian atrophy, and amyotrophic 
lateral sclerosis, have also been identifi ed in hormonally aged human sebocytes. 
These data demonstrate that the skin, and especially its “brain” the sebaceous 
gland, represents an adequate model for neurobiological and ageing research.
Molecular and Cellular Mechanisms Regulating Neurogenic Infl ammation and 
Pruritus
Martin Steinhoff
Depts. of Dermatology and Surgery, University of California San Francisco, San 
Francisco, CA, USA
 
Sensory nerves in the skin regulate a variety of functions such as touch, body 
defense or thermoregulation, for example. Under pathophysiological conditions, 
nerves are implicated in infl ammatory responses and immune defense, and 
transmit pruritus and pain. The cellular and molecular mechanisms involved 
in the regulation of the different neuronal processes are poorly understood. 
Sensory nerve endings release neuromediators that activate specifi c receptors 
on resident target cells or transient immune cells in the skin. Neuromeadiators 
include peptides such as  substance P, calcitonin gene-related peptide (CGRP) 
or PACAP, for example. While some neuropeptides mediate proinfl ammatory 
effects and recruit leukocytes to the site of infl ammation, others are 
capable of downregulating proinfl ammatory cytokines or chemokines.
Proteinases such as tryptase or neutral endopeptidase, for example, inactivate 
neuropeptides in the extracellular space or at the cell surface thereby terminating 
neuropeptide-induced infl ammatory or immune responses. Proteinase-activated 
receptors (PARs) or transient receptor potential ion channels of the vanilloid type 
(capsaicin receptors) are recently described receptors which may have a high 
impact in regulating cutaneous neurogenic infl ammation. Upon stimulation 
by exogenous (temperature changes, irritation, microbes) or endogenous 
(“stress”, hormones, mediators) factors, sensory nerves become activated 
thereby transmitting the stimulus via afferent fi bers to the central nervous system. 
The interaction between the neuronal mediators and their receptors is tightly 
regulated and includes mechanisms of receptor inactivation and resenssitization as 
well as degradation. For example, endothelin-converting enzyme-1 (ECE-1) regulates 
neuroeptide receptor internalization and intracellular cell signaling of MAP kinases 
by degrading the neuropeptide/neuropeptide receptor complex in lysosomes. 
Thus, a close multidirectional interaction between neuromediators, high-affi nity 
receptors and regulatory proteases on nerves, cutaneous cells and immune cells 
guarantees to restore and maintain tissue integrity and terminates infl ammatory 
responses in the skin. Thus, understanding the molecular pathways of neuro-
immune communication represents an important basis for the development of 
therapies in diseases like atopic dermatitis, and of symptoms such as pruritus or pain. 
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Pruritus In Mast Cell-Mediated Diseases
Marcus Maurer and Martin Metz
Dpt. of Dermatology and Allergy, Allergie-Centrum-Charité, Charité - 
Universitätsmedizin Berlin
Pruritic skin lesions are a hallmark feature of mast cell-driven diseases such as urticaria 
and mastocytosis. Mast cells are also involved in the pathogenesis of many other skin 
conditions including psoriasis, atopic dermatitis, and autoinfl ammatory syndromes 
that can come with pruritus. The release of histamine from activated skin mast cells 
and subsequent H1 receptor binding and activation is a key pathway, but not the 
only mechanism, in mast cell-mediated pruritus. Here, we will review classical and 
alternative pathways of how mast cells can induce, modulate and limit pruritus. 
Also, we will discuss the signals and cellular interactions involved in these processes 
and their potential as targets for future approaches to prevent and reduce pruritus. 
The development and introduction to routine clinical practice of novel antipruritic 
treatment options requires the generation, development and validation of better ways 
and instruments to measure pruritus and its impact on patients. We will review the 
instruments currently available to measure pruritus and its impact in clinical practice 
as well as clinical trials. Also, we will present some novels tools for assessing pruritus 
activity and impact on patients’ quality of life and fi rst results obtained from their use.
Brain Functional Magnetic Resonance Imaging (fMRI) in Dermatology
Christopher EM Griffi ths, CE Kleyn
Dermatological Sciences, University of Manchester, Manchester, UK
  
Functional magnetic resonance imaging (fMRI) is a means of measuring brain blood 
fl ow by way of blood oxygen levels.  The science of brain mapping has allowed a 
detailed insight of the relative processing functions of anatomic sites in this organ.  We 
have used fMRI to dissect the neurocognitive mechanisms that mediate the adverse 
consequences of the social stigma associated with visible skin lesions of psoriasis, 
such as disgusted facial expressions of others. Disgust is known to activate the 
insular cortex.  We investigated whether the social impact of psoriasis is associated 
with altered cognitive processing of disgust using a covert recognition of faces task 
conducted with fMRI.  Psoriasis patients had signifi cantly (p<0.005) smaller signal 
responses to disgusted faces in the bilateral insular cortex, compared with healthy 
controls.  We hypothesise that patients develop a coping mechanism to protect them 
from stressful emotional responses by blocking the processing of disgusted facial 
expressions. Itch is the most prevalent symptom of allergic and infl ammatory skin 
disease however, its pathophysiology and neurobiology are not well understood. 
Functional MRI investigation of histamine-induced itch demonstrated positive signal 
in regions including the supplementary motor cortex, premotor cortex and inferior 
parietal lobe, and multifocal negative signal in orbitofrontal, medial frontal and 
anterior cingulate cortices.  Our novel time-series analysis approach demonstrated 
progressive activation of distinct regions of prefrontal cortex in itch perception. 
Improved understanding of both activated and deactivated regions may in the long-
term facilitate development of more effective management strategies for treatment of 
itch. Overall, fMRI is proving a valuable tool for investigation of the “brain-skin” axis.
Back to Clinic – Coping Strategies in Chronic Skin Diseases
Anna Zalewska
Psychodermatology Department, Chair of Clinical Immunology and Microbiology, 
Medical University of Lodz, Poland
Coping is regarded as a set of responses to stressful events by which the patient 
can modulate one’s reactions to stressors and attenuate psychological outcomes. 
Coping strategies could be divided into active coping concentrated mainly on 
problem-solving, expression of emotions and social support seeking or passive 
coping including avoidance and denial. It was demonstrated that combined emotive 
coping strategies were associated with more disability, poorer mental health and 
worse health related quality of life (HRQL) in psoriatic patients. Of note in a one-
year longitudinal study, psoriatic patients initially engaged in coping based on 
expression of emotions, seeking more social support and more distraction and 
less passive coping were prescribed a lower number of different therapies, were 
less anxious, less depressed and had a better physical health one year later. Of 
interest are three coping strategies which use was associated with great decrease 
in all HRQL domains namely telling others about psoriasis, covering the lesions 
and avoiding people. Chronic dermatology patients tend to employ less active 
coping strategies, planning , positive reinterpretation and humor comparing with 
controls. This observation seems to be in line with other chronic medical condition 
patients. It seems that teaching chronic dermatology patients abilities enabling them 
to implement most effective coping strategies could lead to augmentation of self-
esteem, anxiety reduction, improvement in HRQL and better adherence to treatment. 
